David I. Gwynne
Corporate Officer/Principal en NeuroHealing Pharmaceuticals, Inc. .
Origen de la red de primer grado David I. Gwynne.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
NeuroHealing Pharmaceuticals, Inc.
NeuroHealing Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeuroHealing Pharmaceuticals, Inc. develops drug therapies for the post-acute and chronic neuro-rehabilitation patients. Its products include NH001, a dopaminergic agent to help post traumatic brain injury patients to emerge from a coma, vegetative, or minimally consciousness state, NH004, a treatment for the social debilitating condition of sialorrhea, a non-motor complaint of Parkinson's disease patients and NH02D, an orally administered drug for on-demand treatment of premature ejaculation, a male sexual disorder affecting sexually active men. The company was founded by Esteban Fridman and Daniel Katzman in 2003 and is headquartered in Waban, MA.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a David I. Gwynne a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Pervasis Therapeutics, Inc.
Pervasis Therapeutics, Inc. Medical SpecialtiesHealth Technology Pervasis Therapeutics, Inc. is a clinical stage company developing a broad portfolio of biologically active therapeutics. The company was founded by Robert S. Langer Jr. and Helen Marie Nugent in 2004 and is headquartered in Waltham, MA. | Medical Specialties | Corporate Officer/Principal | |
The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal | |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal | |
CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Kleine-Levin Syndrome Foundation, Inc. | Founder | ||
Amherst College | College/University | Undergraduate Degree | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
MG Biotherapeutics LLC | Chief Operating Officer | ||
Monitor
Monitor Financial ConglomeratesFinance Monitor is an American private investment company. | Financial Conglomerates | Corporate Officer/Principal | |
INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Locust Walk Partners LLC
Locust Walk Partners LLC Miscellaneous Commercial ServicesCommercial Services Locust Walk Partners LLC provides commercial supporting and advisory services. The firm involves in securities-related transactions for clients, including mergers and acquisitions, private placements & mezzanine financings and partnerships involving equity investments. The company was founded by Geoff Meyerson and Joseph Mohr in 2008 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
GAMIDA CELL LTD. | Pharmaceuticals: Major | Investor Relations Contact | |
Harvard Business School | College/University | Masters Business Admin | |
LIPAC Oncology LLC
LIPAC Oncology LLC Medical DistributorsDistribution Services LIPAC Oncology LLC engages in the provision of drug delivery services. It offers LiPax, a proliposomal intracavitary paclitaxel drug delivery platform. The company was founded by Ramachandran R. Thirucote, Willem A. Robberts and Michael Oefelein in 2016 and is headquartered in Pomona, CA. | Medical Distributors | Director/Board Member | |
CENTESSA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Universidad Nacional de La Plata | College/University | Undergraduate Degree | |
Oridion Medical Ltd. | Corporate Officer/Principal | ||
Unleash Immuno Oncolytics, Inc.
Unleash Immuno Oncolytics, Inc. BiotechnologyHealth Technology Unleash Immuno Oncolytics, Inc. develops oncolytic virus immunotherapy products to treat cancer. Its product is UIO-512. the company is headquartered in Saint Louis, MO. | Biotechnology | Founder | |
BioPharmAnalysis LLC
BioPharmAnalysis LLC Miscellaneous Commercial ServicesCommercial Services BioPharmAnalysis LLC provides scientific, medical, and technology due diligence consulting and advisory services. The private company is based in New York, NY. The company was founded by Elkan R. Gamzu. | Miscellaneous Commercial Services | Founder | |
CeNeS Pharmaceuticals, Inc.
CeNeS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CeNeS Pharmaceuticals, Inc. discovers and develops proprietary pharmaceuticals to prevent and treat disorders and injuries of the nervous system. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | President | |
CHIASMA, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Wake Forest University | College/University | Director/Board Member | |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Chairman | |
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Hospital/Nursing Management | Director/Board Member | |
Albor Biologics, Inc. | Founder | ||
Alvos Therapeutics, Inc.
Alvos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Arrowhead Pharmaceuticals, Inc., Alvos Therapeutics, Inc. develops novel cancer drugs. The company is based in Wellesley, MA. The company was founded by Mark Wayne Leuchtenberger. Alvos Therapeutics was acquired by Arrowhead Pharmaceuticals, Inc. on April 11, 2012 for $25.50 million. | Pharmaceuticals: Major | Founder | |
ACUSPHERE, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Yale School of Management | College/University | Masters Business Admin | |
XENETIC BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Eterna Therapeutics LLC
Eterna Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Eterna Therapeutics, Inc., Eterna Therapeutics LLC is a clinical-stage biopharmaceutical company based in New York, NY. The company is focused on exploring the role that cytokine-based therapy can have on the immune system in treating patients with cancer. Eterna Therapeutics is committed to developing irx-2, a novel cytokine-based therapy, to treat patients with cancer. The active constituents of irx-2, namely interleukin-2 (il-2) and other key cytokines, are postulated to signal, enhance and restore immune function suppressed by the tumor, thus enabling the immune system to attack cancer cells. Eterna Therapeutics is a late clinical-stage biopharmaceutical company focused on il-2 cytokine-based therapies in treating patients with cancer. Eterna Therapeutics was acquired by NTN Buzztime, Inc. on March 25, 2021 for $213.30 million. | Pharmaceuticals: Major | Chief Executive Officer | |
Aleta Biotherapeutics, Inc.
Aleta Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aleta Biotherapeutics, Inc. engages in the immuno-oncology service that focuses on transforming cellular therapeutics. It allows broad spectrum of cancer indication to be targeted including currently intractable solid tumors. The company was founded by Paul Rennert and Roy Lobb and is headquartered in Natick, MA. | Miscellaneous Commercial Services | Chairman | |
NEUROSENSE THERAPEUTICS LTD. | Pharmaceuticals: Major | Chairman | |
ETERNA THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Spybiotech Ltd.
Spybiotech Ltd. BiotechnologyHealth Technology Spybiotech Ltd. develops molecular superglue which it believes can be used to create vaccines. The company was founded by Sumit Biswas and is headquartered in Oxford, the United Kingdom. | Biotechnology | Chief Executive Officer | |
W WORL | Pharmaceuticals: Major | Director/Board Member | |
Neurotech Pharmaceuticals, Inc. (United States)
Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI. | Pharmaceuticals: Major | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 46 |
Israel | 3 |
Reino Unido | 3 |
Argentina | 2 |
Sectorial
Health Technology | 30 |
Consumer Services | 8 |
Commercial Services | 6 |
Health Services | 3 |
Finance | 2 |
Operativa
Director/Board Member | 20 |
Corporate Officer/Principal | 19 |
Chief Executive Officer | 13 |
President | 11 |
Founder | 8 |
Las relaciones más conectadas
Insiders | |
---|---|
Mark Leuchtenberger | 21 |
Joshua D. Hamermesh | 14 |
Elkan R. Gamzu | 12 |
Neal M. Farber | 8 |
Daniel Katzman | 5 |
Esteban Fridman | 1 |
- Bolsa de valores
- Insiders
- David I. Gwynne
- Conexiones Empresas